[1]
“Harnessing the Innate Effector: A Narrative Review of Advancing Strategies in CAR Engineering, Metabolic Reprogramming, and TME Resistance of Natural Killer Cells for Cancer Immunotherapy”, CBS Int. Journal, vol. 4, no. 11, pp. 349–358, Oct. 2025, doi: 10.59278/cbs.v4i11.70.